Teresa Hagan Thomas1, Karin Nauth-Shelley2, Michael A Thompson3, Deanna J Attai4, Matthew S Katz5, David Graham6, Dee Sparacio7, Christina Lizaso7, Audun Utengen8, Don S Dizon9. 1. University of Pittsburgh School of Nursing, Pittsburgh, PA. 2. ThoughtBoost, Boston, MA. 3. Aurora Research Institute, Aurora Health Care, Milwaukee, WI. 4. University of California, Los Angeles, Los Angeles, CA. 5. Lowell General Hospital, Lowell, MA. 6. Levine Cancer Institute-Mallard Creek, Charlotte, NC. 7. #gyncsm online community. 8. Symplur, Los Angeles, CA. 9. Lifespan Cancer Institute, Rhode Island Hospital, Providence, RI.
Abstract
PURPOSE: Ovarian cancer is the most fatal of all gynecologic cancers, with a high relapse rate regardless of stage. Women treated for ovarian cancer, therefore, likely have supportive care needs that extend well beyond the time frame of first-line therapy. Unfortunately, there is minimal data describing these needs. The purpose of this qualitative study is to understand the supportive care needs of women with ovarian care at the end of treatment. METHODS: To better understand the issues faced by women with ovarian cancer, we conducted a public Twitter chat in collaboration with gynecologic cancer social media (#gyncsm). Both quantitative and qualitative analyses were performed. RESULTS: The chat occurred over a 1-hour time frame on Twitter and resulted in more than 300 unique and original tweets from 43 participants during the chat and an additional 60 unique participants following the chat. Survivors and physicians represented 32% and 11% of participants, respectively; caregivers, advocates, and other clinicians represented the remaining participants. Participants noted deep interest in receiving support during survivorship and dissatisfaction with currently available resources. Sentiment analysis showed that participants viewed the support from social media in a positive light and also revealed negative sentiment around the lack of support from health care providers at the end of treatment. CONCLUSIONS: Themes derived from the Twitter chat revealed the unique experiences of individuals with ovarian cancer after treatment, including a heightened sense of vulnerability. Understanding these themes represents an opportunity for clinicians to better understand and address the needs of this patient community.
PURPOSE: Ovarian cancer is the most fatal of all gynecologic cancers, with a high relapse rate regardless of stage. Women treated for ovarian cancer, therefore, likely have supportive care needs that extend well beyond the time frame of first-line therapy. Unfortunately, there is minimal data describing these needs. The purpose of this qualitative study is to understand the supportive care needs of women with ovarian care at the end of treatment. METHODS: To better understand the issues faced by women with ovarian cancer, we conducted a public Twitter chat in collaboration with gynecologic cancer social media (#gyncsm). Both quantitative and qualitative analyses were performed. RESULTS: The chat occurred over a 1-hour time frame on Twitter and resulted in more than 300 unique and original tweets from 43 participants during the chat and an additional 60 unique participants following the chat. Survivors and physicians represented 32% and 11% of participants, respectively; caregivers, advocates, and other clinicians represented the remaining participants. Participants noted deep interest in receiving support during survivorship and dissatisfaction with currently available resources. Sentiment analysis showed that participants viewed the support from social media in a positive light and also revealed negative sentiment around the lack of support from health care providers at the end of treatment. CONCLUSIONS: Themes derived from the Twitter chat revealed the unique experiences of individuals with ovarian cancer after treatment, including a heightened sense of vulnerability. Understanding these themes represents an opportunity for clinicians to better understand and address the needs of this patient community.
Entities:
Keywords:
Twitter; cancer survivorship; ovarian neoplasm; patient needs; survivorship care plan
Authors: Ritu Salani; Floor J Backes; Michael Fung Kee Fung; Christine H Holschneider; Lynn P Parker; Robert E Bristow; Barbara A Goff Journal: Am J Obstet Gynecol Date: 2011-06 Impact factor: 8.661
Authors: Kim Agnes Helma Nicolaije; Olga Husson; Nicole Paulina Maria Ezendam; Maria Caroline Vos; Rutgerus Franciscus Petrus Maria Kruitwagen; Marnix Lodewijk Maria Lybeert; Lonneke Veronique van de Poll-Franse Journal: Patient Educ Couns Date: 2012-06-01
Authors: Kristina L Mirabeau-Beale; Alice B Kornblith; Richard T Penson; Hang Lee; Annekathryn Goodman; Susana M Campos; Linda Duska; Lauren Pereira; Jessica Bryan; Ursula A Matulonis Journal: Gynecol Oncol Date: 2009-05-28 Impact factor: 5.482
Authors: Katherine B Roland; Juan L Rodriguez; Jennifer Rees Patterson; Katrina F Trivers Journal: Psychooncology Date: 2013-06-13 Impact factor: 3.894
Authors: Kathryn E Weaver; Noreen M Aziz; Neeraj K Arora; Laura P Forsythe; Ann S Hamilton; Ingrid Oakley-Girvan; Gretchen Keel; Keith M Bellizzi; Julia H Rowland Journal: J Oncol Pract Date: 2014-04-01 Impact factor: 3.840
Authors: Elizabeth M Goldberg; Rochelle K Rosen; Don S Dizon; Kirsten J Langdon; Natalie M Davoodi; Tyler B Wray; Nicole R Nugent; Shira I Dunsiger; Megan L Ranney Journal: J Med Internet Res Date: 2022-06-13 Impact factor: 7.076
Authors: Anusha Chidharla; Audun Utengen; Deanna J Attai; Emily K Drake; G J van Londen; Ishwaria M Subbiah; Elizabeth Henry; Martina Murphy; Maura M Barry; Rami Manochakian; Scott Moerdler; Stacy Loeb; Stephanie L Graff; Yan Leyfman; Michael A Thompson; Merry J Markham Journal: JCO Oncol Pract Date: 2022-03-21
Authors: Sara Beltrán Ponce; Maura M Barry; Don S Dizon; Matthew S Katz; Martina Murphy; Eleonora Teplinsky; Stacey Tinianov; Deanna J Attai; Merry Jennifer Markham Journal: Future Oncol Date: 2022-02-03 Impact factor: 3.674
Authors: Karen A Monuszko; Laura J Fish; Dorinda Sparacio; Christina Lizaso; Kathryn Burn; Natalie E Wickenheisser; Larissa A Meyer; Shelby D Reed; Brittany A Davidson; Laura J Havrilesky Journal: Gynecol Oncol Rep Date: 2022-07-26